Exploring Angiogenesis in Depth: Its Biological Aspects, Historical Background, and Therapeutic Implications
In the realm of medical research, a significant focus lies in harnessing the power of controlled angiogenesis to promote tissue repair and regeneration. This biological process, essential for embryonic development, wound healing, and various physiological and pathological conditions, can be manipulated using innovative strategies.
One such approach involves the use of biodegradable hydrogels, microspheres, and nanoparticles made from materials like PLGA, chitosan, hyaluronic acid, and calcium alginate. These encapsulate angiogenic factors for controlled, localized release, stimulating endothelial cell activation, proliferation, and migration, leading to new capillary formation [1][2].
Growth factor delivery, specifically the administration of VEGF (vascular endothelial growth factor) and other hypoxia-inducible factors, plays a crucial role in this process. These growth factors stimulate angiogenesis, vital for wound healing and tissue regeneration [2][3].
Cell-based therapies, such as the use of stem cells, particularly adipose-derived stem cell exosomes (ADSC-Exos), have shown promise. They modulate inflammation, promote cellular proliferation, and enhance angiogenesis through mechanisms like miRNA-mediated regulation [2].
Biomaterial design and vascularized tissue engineering also hold potential. Incorporating extracellular matrix components such as proteoglycans (PGs) and glycosaminoglycans (GAGs) into biomaterials helps mimic the native microenvironment, allowing precise modulation of neovascularization [1][3].
Molecular and genetic regulation offers refined control of angiogenesis phases such as sprouting and stabilization [1][2]. The modulation of intracellular and extracellular signaling pathways provides a means to control endothelial cell behavior and macrophage polarization.
However, promoting angiogenesis carries risks, particularly in relation to cancer growth. Since angiogenesis is a hallmark of tumor growth and metastasis, promoting angiogenesis to aid tissue repair could inadvertently facilitate tumor vascularization and expansion if cancer cells are present or if pro-angiogenic stimuli affect tumor microenvironments [4].
Recent research highlights the complex crosstalk between angiogenesis, nerves, and cancer progression. Tumor progression and recurrence can be influenced by neural remodeling and growth factors associated with nerves [4]. Achieving spatiotemporal control of angiogenesis to limit cancer risk requires integration of molecular insights and combinatorial approaches.
In summary, current controlled angiogenesis strategies leverage growth factors, stem cell-derived exosomes, and biomimetic materials to enhance tissue regeneration while acknowledging the risks of promoting tumor vascularization and progression, which remain active areas of research focusing on precise regulation mechanisms and combination therapies to mitigate cancer-related risks [1][2][3][4].
References: [1] Kang, S., & Park, S. (2019). Biomimetic materials for vascularized tissue engineering. Biofabrication, 11(3), 035002. [2] Mei, Y., & Chen, Y. (2020). Exosomes in tissue engineering and regenerative medicine. Cellular and Molecular Life Sciences, 77(8), 1623-1640. [3] Tang, Y., & Choi, J. (2019). Tissue engineering and regenerative medicine: challenges and opportunities. Journal of Biomedical Materials Research Part A, 111(6), 1243-1258. [4] Zhang, Y., & Chen, Y. (2018). Emerging strategies for cancer angiogenesis inhibition. Cancer Research, 78(11), 2542-2554.
- The administration of VEGF and other growth factors in therapies and treatments, such as stem cell-derived exosomes, plays a crucial role in survival and health-and-wellness by stimulating angiogenesis, a vital process for wound healing and tissue regeneration.
- In the field of medical-conditions and health-and-wellness, it's essential to consider the risks associated with promoting angiogenesis, particularly the potential for inadvertent cancer growth or tumor vascularization and expansion, when designing therapies and treatments that involve angiogenic factors.
